|
NeedingMore220 -> RE: Not just a bladder infection... (8/14/2008 6:31:38 PM)
|
I'm sorry you're in such pain. Where do you figure you would have gotten a chemical burn from? The yeast medicine? Have you used it before - it could be a reaction.
From http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20(General%20Monographs-%20M)/MONISTAT.html
Discontinue medication if sensitization or other signs of irritation (rash, burning, blistering, redness), not present before therapy, occur from intravaginal or topical use. Avoid contact with the eyes.
In general, the complaints reported with miconazole therapy concerned vulvovaginal burning, itching, irritation, pelvic cramping, edema as well as hives and rash.
A total of 1 089 patients participated in clinical evaluations of miconazole nitrate 2% vaginal cream administered in dosage regimens of varying duration. Of these, 59 patients reported reactions which were possibly drug related but not severe enough to cause discontinuation of therapy, 4 patients discontinued therapy due to vulvovaginal burning and itching, and 1 patient discontinued therapy due to hives.
A total of 1 724 patients participated in clinical evaluations of miconazole nitrate 100 mg vaginal suppositories administered in dosage regimens of varying duration. Of these, 3 patients reported reactions which were interpreted as minor treatment emergent signs and symptoms (burning, itching, edema) and considered by the investigators to be nontherapy related. No patients were reported to have discontinued therapy due to drug related reasons.
The 3-day treatment with miconazole nitrate 400 mg vaginal ovules was exceptionally well tolerated by a total of 410 patients in 3 clinical studies, without any related side effects. However, the generally reported complaints referred to above could be expected with this dosage form and regimen as well.
The combination pack products combine a small amount (9 g) of miconazole nitrate 2% cream to be applied externally during a course of therapy with miconazole nitrate vaginal suppositories or ovules so a similar safety and efficacy profile, as with each individually, could be expected.
|
|
|
|
